US20140163608A1 - Implantable sealing device - Google Patents
Implantable sealing device Download PDFInfo
- Publication number
- US20140163608A1 US20140163608A1 US14/101,013 US201314101013A US2014163608A1 US 20140163608 A1 US20140163608 A1 US 20140163608A1 US 201314101013 A US201314101013 A US 201314101013A US 2014163608 A1 US2014163608 A1 US 2014163608A1
- Authority
- US
- United States
- Prior art keywords
- braiding
- sealing device
- elastic member
- sealing
- threads
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0587—Epicardial electrode systems; Endocardial electrodes piercing the pericardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00579—Barbed implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00597—Implements comprising a membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
Definitions
- the present disclosure relates to an implantable sealing device for sealing a tissue opening, more specifically a trocar tube opening in the left ventricle of the heart.
- Deficient heart valves can be repaired or replaced using a variety of different types of heart valve surgeries.
- One general type of heart valve surgery involves an open-heart surgical procedure during which the heart is stopped and blood flow is controlled by a heart-lung bypass machine. This type of valve surgery is highly invasive and exposes the patient to a number of potential risks associated with use of the heart-lung machine.
- TAVI transcatheter aortic valve implantation
- TAAVI transapical aortic valve implantation
- the artificial valve is attached to a compressed stent, the stent being attached to a balloon catheter.
- the balloon catheter is inserted in the femoral artery and guided into the heart to the area of the aortic valve. Once in position, the balloon is inflated to secure the valve in place.
- the replacement valve is inserted through a small incision in the chest wall of a patient and the catheter is advanced through the apex of the heart.
- a balloon catheter is inserted through an introducer, e.g. a trocar tube and guided into the heart to the area of the aortic valve. After valve deployment, the trocar tube is removed and the opening in the ventricular apex is sutured.
- a problem in the transapical procedure is the haemostatic closure of the left ventricular apex.
- a purse string suture is placed in the tissue prior to insertion of the trocar tube to facilitate closure after the procedure is complete. After removing the trocar tube the ends of the suture are drawn tight to close the wound. Due to the high pressure created by the contraction of the heart severe problems may occur when the suture is not tight or disrupts.
- An object of the present disclosure is therefore to provide an improved device for sealing a tissue opening, especially a trocar tube opening in the myocardium after the transapical procedure of valve replacement.
- the device can not only seals the tissue opening itself, such that the primary bleeding is stopped, but also prevent secondary bleeding from occurring.
- the tissue opening should be tightly closed.
- the device is filigree and flexible in order to be able to follow the movement of the heart without the occurrence of structural damage such as e.g. cracks.
- the beating of the heart and the heart rate of the patient should not be affected. Due to its filigree construction the braiding can take the anatomical shape of the apex of the left ventricle, the place where the trocar is introduced.
- a further object of the disclosure is to provide the above required device and to simultaneously provide a possibility to place heart wires in minimally invasive heart surgery procedures.
- the sealing device can include a membrane coated braiding of fine threads. Furthermore a tensioning member and a fixing member are present for placing and anchoring the sealing device into the myocardium.
- a sealing device comprises an elongated elastic member having a distal and a proximal end, at least one sealing element in form of an umbrella shaped braiding having outside and inside faces, the braiding being positioned respectively at the distal and proximal ends of the elastic member, wherein the braiding includes a plurality of fine threads of a memory metal alloy and wherein at least one face of the braiding is coated by a membrane, and a fixing member being positioned respectively at the distal and proximal ends of the elastic member and being positioned opposite to the braiding.
- the braiding may be very soft and flexible in order to avoid injuring the very soft heart tissue.
- the braiding is able to follow the movement of the heart.
- the braiding is adapted to the anatomical shape of the apex of the left ventricle and includes at least 30 fine threads, preferably 30 to 100 threads, more preferably 70 to 90 threads.
- the threads are 0.03 to 0.15 mm in diameter, preferably 0.05 to 0.13 mm in diameter; more preferably circa 0.1 mm in diameter. Due to the number of fine threads the device fulfills the requirement of flexibility and softness.
- the umbrella shaped braiding is preferably made out of Nitinol threads thus allowing the self-deployment of the membrane coated braiding whereby the braiding is adapted to the shape of the apex of the left ventricle due to the shape memory properties of Nitinol.
- the interaction of the sealing member, the elastic member, and the fixing member allows the immediate closure of the opening in the apex of the left ventricle.
- the immediate closure is beneficial due to the high pressure in the left ventricle created by the contraction of the heart and the strong movement of the heart.
- the sealing of the trocar tube opening in the myocardium starts immediately after the placing and fixing of the membrane coated braiding.
- a preferred sealing device comprises an elongated elastic member having distal a and a proximal end, at least one sealing element in form of an umbrella shaped braiding having outside and inside faces, the braiding being positioned respectively at the distal and proximal ends of the elastic member, wherein the braiding includes at least 30 threads made of Nitinol, said threads being 0.03 to 0.15 mm in diameter and wherein at least one face of the braiding is coated by a membrane, and whereby in a position in use the braiding is adapted to the anatomical shape of the apex of the left ventricle, and a fixing member positioned respectively at the distal and proximal ends of the elastic member and being positioned opposite to the braiding.
- At least one membrane coated braiding can be present.
- a second membrane coated braiding may be present positioned opposite to the first membrane coated braiding.
- the membrane coated braiding is preferably positioned at the distal end of the elastic member, thus being positioned at the inner side of the opening in the myocardium in the position of use as shown in FIG. 2 .
- Suitable membranes are made out of biocompatible plastic such as e.g. silicone or polyurethane, preferably silicone. It is important that the membrane is biocompatible and impervious to blood.
- the coating is positioned respectively at the outside face or at inside face of the braiding, preferably at the outside face. If desired, both sides of the braiding may be coated.
- the elongated elastic member is a tensioning element and may be a spring or a member made from elastic biocompatible material like rubber.
- the spring is preferably a coil spring made, for example, from stainless steel, MP35N or Nitinol.
- the fixing member may be any known fixing member which may be deployed from a retracted to an extended position.
- the fixing member includes radially expandable arms, e.g. a pair of radially expandable arms which extend from the elongated elastic member.
- the arms are formed from a bio-compatible material, such as stainless steel, MP35N or Nitinol, preferably Nitinol.
- the fixing member is operatively associated with the elongated elastic member and is mounted for movement between a retracted position wherein the arms are disposed within the interior lumen of the trocar tube and an extended position wherein the arms extend radially outwardly to anchor the elastic member and thus to anchor the umbrella shaped membrane coated braiding in the myocardium thus sealing the opening in the myocardium.
- the radially expandable arms may be different in shape, whereby the shape may influence the anchor effect. Before use, the sealing device is folded and is disposed within the interior lumen of the trocar tube.
- the disclosure further relates to a method for sealing a tissue opening, especially a trocar tube opening in the myocardium at the apex of the left ventricle comprising inserting a trocar tube including a folded sealing device as described herein and guiding the trocar tube through an opening in the myocardium into the patient's left ventricle, pushing the folded umbrella shaped and membrane coated braiding out of the trocar tube so that the umbrella moves from a folded into a deployed position whereas the fixation member remains inside the trocar tube, stretching the elastic member by means of a tensioning cord and pulling the pre-stretched elastic member out of the opening in the myocardium whereby the fixing member is placed against the tissue of the myocardium and moves from a folded into a deployed position, removing the trocar tube whereby the elastic member remains stretched, and removing the tension from the elastic member whereby the fixing member anchors in the tissue of the myocardium.
- FIG. 1 is a schematic illustration of the transapical valve insertion technique
- FIG. 2 shows the sealing device, sealing the inner myocardium
- FIG. 3 show the sealing device, sealing the outer myocardium
- FIG. 4 is a view corresponding to FIG. 1 and in addition shows temporary electrodes inserted for heart stimulation;
- FIGS. 5 a to 5 d show the placing and the affixing of the stimulation electrodes
- FIG. 6 shows a stimulation electrode in detail
- FIGS. 7 a , 7 b and 7 c show the sealing system in detail
- FIGS. 8 , 8 a , 9 , 9 a and 10 , 10 a show the steps of placing and affixing the sealing system.
- FIG. 1 is a schematic illustration of the transapical valve insertion technique and shows the balloon catheter used to insert new artificial heart valves during Transapical Aortic Valve Implantation (TAAVI) according to the state of the art.
- Trocar tube 1 is inserted into the left ventricle 3 of the heart through the myocardium 2 .
- a compressed valve prosthesis constructed from a stainless steel stent with an attached artificial valve 4 is placed on the balloon catheter 5 , inserted into the apex of the left ventricle, and positioned directly inside the diseased aortic valve. Once in position, the balloon is inflated to secure the valve in place. The balloon is then deflated and removed leaving the new valve to function immediately.
- FIG. 2 shows the sealing device sealing the opening in the myocardium.
- Trocar tube 1 via which the sealing device had been inserted, is retracted behind the ventricular apex.
- the opening in the tissue is tightly sealed by the membrane coated braiding 7 which is positioned at the inner myocardium at the distal end of the elastic member 6 .
- the elastic member 6 includes a coil spring.
- the braiding 7 is adapted to the anatomical shape of the apex of the left ventricle.
- the flexible braiding 7 tightly closes the inner tissue of the heart and is anchored by the fixing member which is operatively associated with the coil spring of elastic member 6 .
- the coil spring is stretched by pulling the double thread 9 down. After the placement of the sealing device, the thread 9 may be removed by pulling down one side of the thread 9 so that the thread 9 may slip out.
- FIG. 3 shows the sealing device sealing the outer myocardium.
- the sealing device can be positioned the other way around as described above should the anatomical shape of the left ventricular apex not allow sealing of the inner myocardium.
- the membrane coated braiding 7 is positioned at the outer myocardium.
- FIG. 4 is a view corresponding to FIG. 1 and in addition shows temporary electrodes (heart wires) inserted for heart stimulation.
- Heart wires are normally placed in open heart surgical procedures and are attached to the epicardium to synchronize the heart after the surgery.
- the embodiment according to FIG. 4 provides a possibility to attach heart wires even if the heart is not exposed.
- the catheter 10 is a three-lumen device which comprises a tubular body defining a first inner lumen extending longitudinally there-through for slipping the catheter over the trocar tube and a second and third lumen 11 , 12 which run along each side of the inner lumen allowing temporary electrodes to pass therethrough.
- a Nitinol-stylet 13 which is preferably pre-shaped, is first inserted within said lumen for assisting in steering of the stimulation electrode when implanted.
- FIGS. 5 a to 5 d show insertion of an electrode within the myocardium of the heart.
- a pre-shaped stylet 13 is first inserted within lumen 11 or 12 and guided from outside of the heart into and through the myocardium.
- the tip of the stylet 13 leaves the tissue of the myocardium.
- a coil 14 is then guided over the stylet towards its tip.
- the stylet 13 is then withdrawn and the temporary electrode 15 is inserted via the lumen of the coil 14 .
- the proximal portion of electrode 15 is connected to an external pacemaker.
- the stimulating procedure is the same procedure as the placing of heart wires which are used in open heart surgical procedures if it is expected that the patient will need stimulation for a limited time after the surgery. After completion of temporary stimulation the heart wires are removed by pulling.
- FIG. 6 shows a stimulation electrode comprising, at its distal end, a loop 16 and a fixing member.
- the stimulation electrode is inserted by means of coil 17 .
- FIGS. 7 a , 7 b and 7 c show the sealing system in detail.
- FIG. 7 a is a top view of the umbrella shaped braiding 7 .
- the braiding can include about 80 Nitinol threads having a diameter of about 0.1 mm.
- FIG. 7 b is a side view of the sealing device.
- Coil spring of elastic member 6 is attached to the braiding 7 at its distal end.
- the fixing member 8 is operatively associated with the coil spring at its proximal end.
- Loop 73 allows double thread 9 to pass therethrough. Socket 72 may hold the ends of the braiding threads.
- the braiding 7 In unfolded condition the braiding 7 can be umbrella shaped or any other suitable shape.
- the coating is positioned at the outside face 70 or at the inside face 71 of the braiding 7 , preferably at the outside face. If desired, both sides of the braiding 7 may be coated.
- FIG. 7 c shows the braiding 7 in the shape adapted to the anatomical shape of the apex of the left ventricle as shown in use in FIG. 2 .
- FIGS. 8 , 9 , and 10 show the steps of placing and affixing the sealing system.
- FIG. 8 shows the sealing device positioned inside trocar tube 1 before placing the device into the left ventricle. Braiding 7 and fixing member 8 are folded. The stick 20 is for pushing out the sealing device. The folding may be upwards ( FIG. 8 ) or downwards ( FIG. 8 a ).
- FIGS. 9 and 9 a show the trocar tube placed in the myocardium functioning as a portal for the subsequent placement of the sealing device.
- the braiding 7 is pushed out of the trocar tube 1 and is unfolded.
- the fixing member 8 is inside the tube 1 and thus still protected.
- FIG. 9 and FIG. 9 a differ in the anatomical shape of the apex of the left ventricle and show the adaption of the shape of the braiding 7 to the different anatomical shapes.
- FIGS. 10 and 10 a show the sealing device placed and the trocar tube 1 removed.
- coil spring of the elastic member 6 is pre-stretched.
- the pre-stretched coil spring is pulled downwards out of the opening in the myocardium.
- the fixing member 8 moves from a folded into a deployed position and anchors in the myocardium tissue.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Surgical Instruments (AREA)
Abstract
An implantable sealing device is disclosed herein and includes an elongated elastic member having distal and a proximal ends, at least one sealing element including braiding having outside and inside faces. The braiding can include of a plurality of fine threads of a memory metal alloy and wherein at least one face of the braiding is coated by a membrane. The braiding can also include a fixing member positioned at one of the distal and proximal ends of the elastic member and being positioned opposite to the braiding.
Description
- This application claims priority under 35 U.S.C. §119(a) to European Patent Application No. EP12008240, filed with the European Patent Office on Dec. 10, 2012, the content of which is incorporated by reference herein in its entirety.
- 1. Field of the Invention
- The present disclosure relates to an implantable sealing device for sealing a tissue opening, more specifically a trocar tube opening in the left ventricle of the heart.
- 2. Description of Related Art
- Deficient heart valves can be repaired or replaced using a variety of different types of heart valve surgeries. One general type of heart valve surgery involves an open-heart surgical procedure during which the heart is stopped and blood flow is controlled by a heart-lung bypass machine. This type of valve surgery is highly invasive and exposes the patient to a number of potential risks associated with use of the heart-lung machine.
- Due to the drawbacks of open-heart surgical procedures, there has been an increased interest in minimally invasive and percutaneous replacement of cardiac valves. Such surgical techniques involve making a relatively small opening in the chest of the patient into which a valve assembly is inserted and delivered into the heart via the operating device of a so-called trocar tube. The minimally invasive methods include reduced pain due to smaller incisions and less bleeding, shorter recovery time, and, especially, avoid the use of a heart-lung machine.
- Minimally invasive surgical procedures such as transcatheter aortic valve implantation (TAVI) and transapical aortic valve implantation (TAAVI) have become feasible alternatives to open techniques in high risk patients.
- In the TAVI process, the artificial valve is attached to a compressed stent, the stent being attached to a balloon catheter. The balloon catheter is inserted in the femoral artery and guided into the heart to the area of the aortic valve. Once in position, the balloon is inflated to secure the valve in place.
- In the TAAVI approach, the replacement valve is inserted through a small incision in the chest wall of a patient and the catheter is advanced through the apex of the heart. Like in the TAVI approach, a balloon catheter is inserted through an introducer, e.g. a trocar tube and guided into the heart to the area of the aortic valve. After valve deployment, the trocar tube is removed and the opening in the ventricular apex is sutured.
- A problem in the transapical procedure is the haemostatic closure of the left ventricular apex. Frequently, a purse string suture is placed in the tissue prior to insertion of the trocar tube to facilitate closure after the procedure is complete. After removing the trocar tube the ends of the suture are drawn tight to close the wound. Due to the high pressure created by the contraction of the heart severe problems may occur when the suture is not tight or disrupts.
- An object of the present disclosure is therefore to provide an improved device for sealing a tissue opening, especially a trocar tube opening in the myocardium after the transapical procedure of valve replacement. The device can not only seals the tissue opening itself, such that the primary bleeding is stopped, but also prevent secondary bleeding from occurring. The tissue opening should be tightly closed. Furthermore, the device is filigree and flexible in order to be able to follow the movement of the heart without the occurrence of structural damage such as e.g. cracks. The beating of the heart and the heart rate of the patient should not be affected. Due to its filigree construction the braiding can take the anatomical shape of the apex of the left ventricle, the place where the trocar is introduced.
- A further object of the disclosure is to provide the above required device and to simultaneously provide a possibility to place heart wires in minimally invasive heart surgery procedures.
- The sealing device can include a membrane coated braiding of fine threads. Furthermore a tensioning member and a fixing member are present for placing and anchoring the sealing device into the myocardium.
- In some embodiments, a sealing device according to the present disclosure comprises an elongated elastic member having a distal and a proximal end, at least one sealing element in form of an umbrella shaped braiding having outside and inside faces, the braiding being positioned respectively at the distal and proximal ends of the elastic member, wherein the braiding includes a plurality of fine threads of a memory metal alloy and wherein at least one face of the braiding is coated by a membrane, and a fixing member being positioned respectively at the distal and proximal ends of the elastic member and being positioned opposite to the braiding.
- The braiding may be very soft and flexible in order to avoid injuring the very soft heart tissue. The braiding is able to follow the movement of the heart. The braiding is adapted to the anatomical shape of the apex of the left ventricle and includes at least 30 fine threads, preferably 30 to 100 threads, more preferably 70 to 90 threads. The threads are 0.03 to 0.15 mm in diameter, preferably 0.05 to 0.13 mm in diameter; more preferably circa 0.1 mm in diameter. Due to the number of fine threads the device fulfills the requirement of flexibility and softness.
- The umbrella shaped braiding is preferably made out of Nitinol threads thus allowing the self-deployment of the membrane coated braiding whereby the braiding is adapted to the shape of the apex of the left ventricle due to the shape memory properties of Nitinol.
- The interaction of the sealing member, the elastic member, and the fixing member allows the immediate closure of the opening in the apex of the left ventricle. The immediate closure is beneficial due to the high pressure in the left ventricle created by the contraction of the heart and the strong movement of the heart. The sealing of the trocar tube opening in the myocardium starts immediately after the placing and fixing of the membrane coated braiding.
- A preferred sealing device comprises an elongated elastic member having distal a and a proximal end, at least one sealing element in form of an umbrella shaped braiding having outside and inside faces, the braiding being positioned respectively at the distal and proximal ends of the elastic member, wherein the braiding includes at least 30 threads made of Nitinol, said threads being 0.03 to 0.15 mm in diameter and wherein at least one face of the braiding is coated by a membrane, and whereby in a position in use the braiding is adapted to the anatomical shape of the apex of the left ventricle, and a fixing member positioned respectively at the distal and proximal ends of the elastic member and being positioned opposite to the braiding.
- At least one membrane coated braiding can be present. When additional sealing may be necessary a second membrane coated braiding may be present positioned opposite to the first membrane coated braiding.
- The membrane coated braiding is preferably positioned at the distal end of the elastic member, thus being positioned at the inner side of the opening in the myocardium in the position of use as shown in
FIG. 2 . - Suitable membranes are made out of biocompatible plastic such as e.g. silicone or polyurethane, preferably silicone. It is important that the membrane is biocompatible and impervious to blood.
- The coating is positioned respectively at the outside face or at inside face of the braiding, preferably at the outside face. If desired, both sides of the braiding may be coated.
- The elongated elastic member is a tensioning element and may be a spring or a member made from elastic biocompatible material like rubber. The spring is preferably a coil spring made, for example, from stainless steel, MP35N or Nitinol.
- The fixing member may be any known fixing member which may be deployed from a retracted to an extended position. Preferably the fixing member includes radially expandable arms, e.g. a pair of radially expandable arms which extend from the elongated elastic member. The arms are formed from a bio-compatible material, such as stainless steel, MP35N or Nitinol, preferably Nitinol. The fixing member is operatively associated with the elongated elastic member and is mounted for movement between a retracted position wherein the arms are disposed within the interior lumen of the trocar tube and an extended position wherein the arms extend radially outwardly to anchor the elastic member and thus to anchor the umbrella shaped membrane coated braiding in the myocardium thus sealing the opening in the myocardium. The radially expandable arms may be different in shape, whereby the shape may influence the anchor effect. Before use, the sealing device is folded and is disposed within the interior lumen of the trocar tube.
- The disclosure further relates to a method for sealing a tissue opening, especially a trocar tube opening in the myocardium at the apex of the left ventricle comprising inserting a trocar tube including a folded sealing device as described herein and guiding the trocar tube through an opening in the myocardium into the patient's left ventricle, pushing the folded umbrella shaped and membrane coated braiding out of the trocar tube so that the umbrella moves from a folded into a deployed position whereas the fixation member remains inside the trocar tube, stretching the elastic member by means of a tensioning cord and pulling the pre-stretched elastic member out of the opening in the myocardium whereby the fixing member is placed against the tissue of the myocardium and moves from a folded into a deployed position, removing the trocar tube whereby the elastic member remains stretched, and removing the tension from the elastic member whereby the fixing member anchors in the tissue of the myocardium.
- These and other features of the systems and methods of the subject disclosure will become more readily apparent to those skilled in the art from the following detailed description taken in conjunction with the drawings.
- So that those skilled in the art to which the subject disclosure appertains will readily understand how to make and use the devices and methods of the subject disclosure without undue experimentation, embodiments thereof will be described in detail herein below with reference to certain figures, wherein:
-
FIG. 1 is a schematic illustration of the transapical valve insertion technique; -
FIG. 2 shows the sealing device, sealing the inner myocardium; -
FIG. 3 show the sealing device, sealing the outer myocardium; -
FIG. 4 is a view corresponding toFIG. 1 and in addition shows temporary electrodes inserted for heart stimulation; -
FIGS. 5 a to 5 d show the placing and the affixing of the stimulation electrodes; -
FIG. 6 shows a stimulation electrode in detail; -
FIGS. 7 a, 7 b and 7 c show the sealing system in detail; and -
FIGS. 8 , 8 a, 9, 9 a and 10, 10 a, show the steps of placing and affixing the sealing system. - Reference will now be made to the drawings wherein like reference numerals identify similar structural features or aspects of the subject disclosure.
FIG. 1 is a schematic illustration of the transapical valve insertion technique and shows the balloon catheter used to insert new artificial heart valves during Transapical Aortic Valve Implantation (TAAVI) according to the state of the art.Trocar tube 1 is inserted into theleft ventricle 3 of the heart through themyocardium 2. A compressed valve prosthesis constructed from a stainless steel stent with an attachedartificial valve 4 is placed on theballoon catheter 5, inserted into the apex of the left ventricle, and positioned directly inside the diseased aortic valve. Once in position, the balloon is inflated to secure the valve in place. The balloon is then deflated and removed leaving the new valve to function immediately. -
FIG. 2 shows the sealing device sealing the opening in the myocardium.Trocar tube 1, via which the sealing device had been inserted, is retracted behind the ventricular apex. The opening in the tissue is tightly sealed by the membrane coatedbraiding 7 which is positioned at the inner myocardium at the distal end of theelastic member 6. As shown in the embodiment ofFIG. 2 , theelastic member 6 includes a coil spring. Thebraiding 7 is adapted to the anatomical shape of the apex of the left ventricle. - The
flexible braiding 7 tightly closes the inner tissue of the heart and is anchored by the fixing member which is operatively associated with the coil spring ofelastic member 6. The coil spring is stretched by pulling thedouble thread 9 down. After the placement of the sealing device, thethread 9 may be removed by pulling down one side of thethread 9 so that thethread 9 may slip out. -
FIG. 3 shows the sealing device sealing the outer myocardium. The sealing device can be positioned the other way around as described above should the anatomical shape of the left ventricular apex not allow sealing of the inner myocardium. In this case the membrane coatedbraiding 7 is positioned at the outer myocardium. -
FIG. 4 is a view corresponding toFIG. 1 and in addition shows temporary electrodes (heart wires) inserted for heart stimulation. Heart wires are normally placed in open heart surgical procedures and are attached to the epicardium to synchronize the heart after the surgery. The embodiment according toFIG. 4 provides a possibility to attach heart wires even if the heart is not exposed. - An
additional catheter 10 is slipped over thetrocar tube 1. Thecatheter 10 is a three-lumen device which comprises a tubular body defining a first inner lumen extending longitudinally there-through for slipping the catheter over the trocar tube and a second andthird lumen stylet 13, which is preferably pre-shaped, is first inserted within said lumen for assisting in steering of the stimulation electrode when implanted. -
FIGS. 5 a to 5 d show insertion of an electrode within the myocardium of the heart. Apre-shaped stylet 13 is first inserted withinlumen stylet 13 leaves the tissue of the myocardium. Acoil 14 is then guided over the stylet towards its tip. Thestylet 13 is then withdrawn and thetemporary electrode 15 is inserted via the lumen of thecoil 14. The proximal portion ofelectrode 15 is connected to an external pacemaker. The stimulating procedure is the same procedure as the placing of heart wires which are used in open heart surgical procedures if it is expected that the patient will need stimulation for a limited time after the surgery. After completion of temporary stimulation the heart wires are removed by pulling. -
FIG. 6 shows a stimulation electrode comprising, at its distal end, aloop 16 and a fixing member. The stimulation electrode is inserted by means ofcoil 17. -
FIGS. 7 a, 7 b and 7 c show the sealing system in detail.FIG. 7 a is a top view of the umbrella shapedbraiding 7. In some embodiments, the braiding can include about 80 Nitinol threads having a diameter of about 0.1 mm.FIG. 7 b is a side view of the sealing device. Coil spring ofelastic member 6 is attached to thebraiding 7 at its distal end. The fixingmember 8 is operatively associated with the coil spring at its proximal end.Loop 73 allowsdouble thread 9 to pass therethrough.Socket 72 may hold the ends of the braiding threads. In unfolded condition thebraiding 7 can be umbrella shaped or any other suitable shape. The coating is positioned at theoutside face 70 or at theinside face 71 of thebraiding 7, preferably at the outside face. If desired, both sides of thebraiding 7 may be coated.FIG. 7 c shows thebraiding 7 in the shape adapted to the anatomical shape of the apex of the left ventricle as shown in use inFIG. 2 . -
FIGS. 8 , 9, and 10 show the steps of placing and affixing the sealing system.FIG. 8 shows the sealing device positioned insidetrocar tube 1 before placing the device into the left ventricle.Braiding 7 and fixingmember 8 are folded. Thestick 20 is for pushing out the sealing device. The folding may be upwards (FIG. 8 ) or downwards (FIG. 8 a). -
FIGS. 9 and 9 a show the trocar tube placed in the myocardium functioning as a portal for the subsequent placement of the sealing device. Thebraiding 7 is pushed out of thetrocar tube 1 and is unfolded. The fixingmember 8 is inside thetube 1 and thus still protected.FIG. 9 and FIG. 9 a differ in the anatomical shape of the apex of the left ventricle and show the adaption of the shape of thebraiding 7 to the different anatomical shapes. -
FIGS. 10 and 10 a show the sealing device placed and thetrocar tube 1 removed. By pullingdouble thread 9 downwards coil spring of theelastic member 6 is pre-stretched. The pre-stretched coil spring is pulled downwards out of the opening in the myocardium. After removing thetrocar tube 1 whereby the double thread is still stretched the fixingmember 8 moves from a folded into a deployed position and anchors in the myocardium tissue. - While the apparatus and methods of the subject disclosure have been shown and described with reference to embodiments, those skilled in the art will readily appreciate that changes and/or modifications may be made thereto without departing from the spirit and scope of the subject disclosure.
Claims (19)
1. An implantable sealing device comprising:
a) an elongated elastic member having a distal end and a proximal end;
b) at least one sealing element comprising a braiding including an umbrella shape and having outside and inside faces, the braiding being positioned respectively at one of the distal and proximal ends of the elastic member, wherein the braiding includes a plurality of fine threads of a memory metal alloy and wherein at least one face of the braiding is coated by a membrane; and
c) a fixing member being positioned respectively at the distal and proximal ends of the elastic member and being positioned opposite to the braiding.
2. The sealing device according to claim 1 , wherein the braiding includes at least 30 threads made of Nitinol.
3. The sealing device according to claim 1 , wherein said threads are about 0.03 mm to about 0.15 mm in diameter
4. The sealing device according to claim 1 , wherein the braiding is configured to adapt to an anatomical shape of an apex of a left ventricle when in use.
5. The sealing device according to claim 2 , wherein the braiding includes 30 to 100 threads.
6. The sealing device according to claim 2 , wherein the braiding includes about 70 to about 90 threads and wherein the threads are about 0.05 mm to about 0.13 mm in diameter.
7. The sealing device according to claim 2 , wherein the braiding includes about 70 to about 90 threads and wherein the threads are about 0.1 mm in diameter.
8. The sealing device according to claim 1 , wherein the braiding is positioned at the distal end of the elastic member.
9. The sealing device according to claim 1 , wherein the membrane is a biocompatible plastic.
10. The sealing device according to claim 1 , wherein the biocompatible plastic is silicone or polyurethane.
11. The sealing device according to claim 1 , wherein the outside face of the braiding is membrane coated.
12. The sealing device according to claim 1 , wherein the elastic member is a coil spring.
13. The sealing device according to claim 1 , wherein the fixing member includes radially expandable arms.
14. The sealing device according to claim 1 , wherein the device is folded inside the tube of the trocar.
15. A method for sealing a tissue opening, especially a trocar tube opening in a myocardium at an apex of a left ventricle comprising the steps of:
a) inserting a trocar tube including a folded sealing device and guiding the trocar tube through an opening in a myocardium into a patient's left ventricle, the sealing device comprising:
i) an elongated elastic member having a distal and a proximal end;
ii) at least one sealing element comprising a braiding extending radially from the elongated elastic member having outside and inside faces, the braiding being positioned respectively at one of the distal and proximal ends of the elastic member, wherein the braiding includes a plurality of fine threads of a memory metal alloy and wherein at least one face of the braiding is coated by a membrane; and
iii) a fixing member being positioned respectively at the distal and proximal ends of the elastic member and being positioned opposite to the braiding;
b) pushing the braiding out of the trocar tube so that the umbrella moves from a folded position into a deployed position whereas the fixing member remains inside the trocar tube;
c) stretching the elastic member by means of a tensioning cord and pulling the pre-stretched elastic member out of the opening in a myocardium whereby the fixing member is placed against a tissue of a myocardium and moves from a folded position into a deployed position;
d) removing the trocar tube whereby the elastic member remains stretched; and
e) removing tension from the elastic member whereby the fixing member anchors in a tissue of a myocardium.
16. A tissue sealing device, comprising:
a) an elongated elastic member having a first end and a second end;
b) a braided sealing member disposed on at least one of the first and second ends, the braided sealing member configured to radially extend upon release from an insertion device;
c) an anchor member disposed on the at least one of the first and second ends, the anchor member configured to anchor the elongated member to tissue, wherein the elongated elastic member provides a compressive force between the braided sealing member and the anchor member such that tissue is compressed therebetween upon anchoring of the tissue sealing device.
17. The sealing device according to claim 16 , wherein the braided sealing member includes threads of a shape memory material.
18. The sealing device according to claim 17 , wherein the threads are about 0.03 mm to about 0.15 mm in diameter.
19. The sealing device according to claim 16 , wherein the braided sealing member includes an umbrella shape.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/816,217 US10758217B2 (en) | 2012-12-10 | 2017-11-17 | Implantable sealing device |
US15/963,722 US10716552B2 (en) | 2012-12-10 | 2018-04-26 | Implantable sealing device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPEP12008240.9 | 2012-12-10 | ||
EP12008240.9A EP2740412B1 (en) | 2012-12-10 | 2012-12-10 | Implantable closure system with membrane-covered shape-memory braid |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/816,217 Division US10758217B2 (en) | 2012-12-10 | 2017-11-17 | Implantable sealing device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140163608A1 true US20140163608A1 (en) | 2014-06-12 |
Family
ID=47602714
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/101,013 Abandoned US20140163608A1 (en) | 2012-12-10 | 2013-12-09 | Implantable sealing device |
US15/816,217 Active 2034-12-13 US10758217B2 (en) | 2012-12-10 | 2017-11-17 | Implantable sealing device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/816,217 Active 2034-12-13 US10758217B2 (en) | 2012-12-10 | 2017-11-17 | Implantable sealing device |
Country Status (2)
Country | Link |
---|---|
US (2) | US20140163608A1 (en) |
EP (1) | EP2740412B1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130312762A1 (en) * | 2012-05-23 | 2013-11-28 | Nandhika Wijay | Reversible Acute Occlusion Implant, Delivery Catheter and Method |
US20160228109A1 (en) * | 2015-02-10 | 2016-08-11 | Vascular Solution, Inc. | Closure device for sealing percutaneous opening in a vessel |
US20170014114A1 (en) * | 2014-03-27 | 2017-01-19 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
JP2017510407A (en) * | 2014-03-27 | 2017-04-13 | ラフィー・ナッサーRAFIEE, Nasser | Apparatus and method for closure of a transvascular or transventricular access port |
US20170319189A1 (en) * | 2012-02-29 | 2017-11-09 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US10441267B2 (en) | 2014-12-02 | 2019-10-15 | 4Tech Inc. | Tissue anchors with hemostasis seal |
CN113081131A (en) * | 2021-04-06 | 2021-07-09 | 苏州茵络医疗器械有限公司 | Auxiliary system for transapical operation |
US11839543B2 (en) | 2012-11-07 | 2023-12-12 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102019115022A1 (en) * | 2019-06-04 | 2020-12-10 | Wolfgang Herzberg | Device for in vivo measurement of an electrophysiological variable |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040220610A1 (en) * | 1999-11-08 | 2004-11-04 | Kreidler Marc S. | Thin film composite lamination |
US20050177182A1 (en) * | 2003-12-04 | 2005-08-11 | Van Der Burg Erik J. | System and method for delivering a left atrial appendage containment device |
US20070208376A1 (en) * | 2006-03-03 | 2007-09-06 | Jian Meng | Occlusion device with internal fastener |
US20080033425A1 (en) * | 2006-05-30 | 2008-02-07 | Coherex Medical, Inc. | Methods, systems, and devices for sensing, measuring, and controlling closure of a patent foramen ovale |
US20080200945A1 (en) * | 2004-03-19 | 2008-08-21 | Aga Medical Corporation | Device for occluding vascular defects |
DE202010011724U1 (en) * | 2010-08-23 | 2010-11-04 | Osypka Ag | Closure system for openings or defects in organs |
WO2011156782A1 (en) * | 2010-06-11 | 2011-12-15 | Entourage Medical Technologies, Llc | System and method for transapical access and closure |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8366743B2 (en) * | 2005-01-28 | 2013-02-05 | Lifetech Scientific (Shenzhen) Co., Ltd | Heart septal defect occlusion device |
US20060229670A1 (en) * | 2005-04-01 | 2006-10-12 | Bates Brian L | Method and a medical closure system for sealing a puncture |
DE102009060770A1 (en) * | 2009-12-30 | 2011-07-07 | Bentley Surgical GmbH, 72379 | Medical implant for closing vascular openings |
WO2013104079A2 (en) * | 2012-01-09 | 2013-07-18 | Endoheart Ag | Electrophysiological endocardiology tool |
-
2012
- 2012-12-10 EP EP12008240.9A patent/EP2740412B1/en not_active Not-in-force
-
2013
- 2013-12-09 US US14/101,013 patent/US20140163608A1/en not_active Abandoned
-
2017
- 2017-11-17 US US15/816,217 patent/US10758217B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040220610A1 (en) * | 1999-11-08 | 2004-11-04 | Kreidler Marc S. | Thin film composite lamination |
US20050177182A1 (en) * | 2003-12-04 | 2005-08-11 | Van Der Burg Erik J. | System and method for delivering a left atrial appendage containment device |
US20080200945A1 (en) * | 2004-03-19 | 2008-08-21 | Aga Medical Corporation | Device for occluding vascular defects |
US20070208376A1 (en) * | 2006-03-03 | 2007-09-06 | Jian Meng | Occlusion device with internal fastener |
US20080033425A1 (en) * | 2006-05-30 | 2008-02-07 | Coherex Medical, Inc. | Methods, systems, and devices for sensing, measuring, and controlling closure of a patent foramen ovale |
WO2011156782A1 (en) * | 2010-06-11 | 2011-12-15 | Entourage Medical Technologies, Llc | System and method for transapical access and closure |
DE202010011724U1 (en) * | 2010-08-23 | 2010-11-04 | Osypka Ag | Closure system for openings or defects in organs |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10966698B2 (en) * | 2012-02-29 | 2021-04-06 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US11957328B2 (en) | 2012-02-29 | 2024-04-16 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US20170319189A1 (en) * | 2012-02-29 | 2017-11-09 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US9597223B2 (en) * | 2012-05-23 | 2017-03-21 | Nandhika Wijay | Reversible acute occlusion implant, delivery catheter and method |
US20130312762A1 (en) * | 2012-05-23 | 2013-11-28 | Nandhika Wijay | Reversible Acute Occlusion Implant, Delivery Catheter and Method |
US11839543B2 (en) | 2012-11-07 | 2023-12-12 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
US20170014114A1 (en) * | 2014-03-27 | 2017-01-19 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
JP2017510407A (en) * | 2014-03-27 | 2017-04-13 | ラフィー・ナッサーRAFIEE, Nasser | Apparatus and method for closure of a transvascular or transventricular access port |
US10058315B2 (en) * | 2014-03-27 | 2018-08-28 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
US10441267B2 (en) | 2014-12-02 | 2019-10-15 | 4Tech Inc. | Tissue anchors with hemostasis seal |
US10588618B2 (en) | 2014-12-02 | 2020-03-17 | 4Tech Inc. | Tissue anchors with hemostasis seal |
US11006946B2 (en) | 2014-12-02 | 2021-05-18 | 4Tech Inc. | Tissue anchors with hemostasis seal |
US11337686B2 (en) | 2014-12-02 | 2022-05-24 | 4Tech Inc. | Off-center tissue anchors |
US11484303B2 (en) | 2014-12-02 | 2022-11-01 | 4Tech Inc. | Off-center tissue anchors |
US11497485B2 (en) | 2014-12-02 | 2022-11-15 | 4Tech Inc. | Off-center tissue anchors |
US10722225B2 (en) | 2015-02-10 | 2020-07-28 | Teleflex Life Sciences Limited | Closure device for sealing percutaneous opening in a vessel |
US10016188B2 (en) * | 2015-02-10 | 2018-07-10 | Teleflex Innovation S.à.r.l. | Closure device for sealing percutaneous opening in a vessel |
US20160228109A1 (en) * | 2015-02-10 | 2016-08-11 | Vascular Solution, Inc. | Closure device for sealing percutaneous opening in a vessel |
CN113081131A (en) * | 2021-04-06 | 2021-07-09 | 苏州茵络医疗器械有限公司 | Auxiliary system for transapical operation |
Also Published As
Publication number | Publication date |
---|---|
EP2740412B1 (en) | 2016-01-20 |
EP2740412A1 (en) | 2014-06-11 |
US10758217B2 (en) | 2020-09-01 |
US20180070934A1 (en) | 2018-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10758217B2 (en) | Implantable sealing device | |
US20210315558A1 (en) | Devices and methods for delivery of expandable prostheses | |
US10499949B2 (en) | Systems for implanting and using a conduit within a tissue wall | |
US10245141B2 (en) | Implant device and implantation kit | |
US20140371789A1 (en) | Minimally invasive surgical techniques | |
DK2858599T3 (en) | Cardiac valve annuloplasty device | |
EP2222248B1 (en) | Cardiac valve downsizing device | |
US20130226288A1 (en) | Minimally invasive surgical techniques | |
US20070168013A1 (en) | Vascular graft and deployment system | |
US20060282161A1 (en) | Valve annulus reduction system | |
CN105555231A (en) | Epicardial anchor devices and methods | |
US20130197559A1 (en) | Minimally invasive surgical techniques | |
US11890193B2 (en) | System and method for reducing tricuspid regurgitation | |
EP3906892A1 (en) | Intraoperative stent and use method therefor | |
US20130197571A1 (en) | Minimally invasive surgical techniques | |
US10716552B2 (en) | Implantable sealing device | |
WO2023196243A1 (en) | Systems and methods for shunting and device implantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PETER OSYPKA STIFTUNG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OSYPKA, PETER;REEL/FRAME:032450/0561 Effective date: 20140310 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |